Table 2.
Clinical and demographic parameters of patients participating in the study.
| Diagnosis | Number | Age (y) | Duration (mo) |
ANC (/mm3) |
Hb (g/dL) |
Plts (103/mm3) |
Ret% | Therapy |
|---|---|---|---|---|---|---|---|---|
| Untreated SAA | 9 | 33 (5–69) | 2 (1–4) | 0.31 ± 0.20 | 82.11 ± 20.01 | 11.22 ± 5.85 | 0.45 ± 0.39 | Not previously treated except for transfusions |
| Recovering SAA | 18 | 20 (5–48) | 24 (6–120) | 3.33 ± 1.22 | 118.94 ± 16.78 | 89.35 ± 43.08 | 1.14 ± 0.27 | Treated with combination indicated |
| Recovering group before combination treatment except transfusion | 18 | 18 (4–47) | Unable to be determined for some patients | 0.21 ± 0.15 | 72.12 ± 23.58 | 9.71 ± 4.89 | 0.25 ± 0.20 | Not previously treated except for transfusions |
Values are mean ± SEM. Age and duration values are mid (min, max). ANC: absolute neutrophil count; Hb: hemoglobin; Plt: platelet; Ret: reticulocyte.